The Impact of COVID-19 Lockdown on Injuries in Saudi Arabia: Results From a Level-I Trauma Center

by Faisal F. Hakeem, Saeed Mastour Alshahrani, Mohammed Al Ghobain, Mohammed Al Ghobain, Mohammed Al Ghobain, Ibrahim Albabtain, Omar Aldibasi, Omar Aldibasi, Suliman Alghnam, Suliman Alghnam
Published 2021-07-01

A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised contro...

by Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar
Published 2020-10-01

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

by Majed Al-Jeraisy, Ahmed Alaskar, Majid Alshamrani, Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar Alqahtani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohammed Asiri, Sameera AlJohani
Published 2021-04-01

Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia

by Naif Khalaf Alharbi, Suliman Alghnam, Abdullah Algaissi, Hind Albalawi, Mohammed W. Alenazi, Areeb M. Albargawi, Abdullah G. Alharbi, Abdulaziz Alhazmi, Ali Al Qarni, Ali Alfarhan, Hosam M. Zowawi, Hind Alhatmi, Jahad Alghamdi, Fayhan Alroqi, Khalid Batarfi, Yaseen M. Arabi, Anwar M. Hashem, Mohammed Bosaeed, Omar Aldibasi
Published 2021-07-01